2:20 PM
 | 
Jan 04, 2019
 |  BC Extra  |  Financial News

InnoCare raises $160M to advance Btk inhibitor

InnoCare Pharma Ltd. (Beijing, China) said Friday that it raised $160 million in a venture round led by Loyal Valley Capital with participation from 3H...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >